News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Client Alert February 19, 2026
Key Themes and Takeaways from the FFA 2026 Global Fund Finance Symposium
Gibson Dunn’s market-leading Fund Finance & Structured Capital team participated in panel discussions and contributed to conversations on the evolution …
Firm News August 13, 2025
Gibson Dunn Represented Advance Auto Parts in Connection with $1.0 Billion Credit Facility
Gibson Dunn represented Advance Auto Parts, Inc. in connection with its new $1.0 billion asset-based loan revolving credit facility.
Firm News August 11, 2025
Gibson Dunn Advises Arrowhead Pharmaceuticals on Asset Purchase Agreement Between Sanofi and Visirna Therapeutics
Gibson Dunn is advising Arrowhead Pharmaceuticals on an asset purchase agreement between Sanofi and Visirna Therapeutics, a majority-owned subsidiary of Arrowhead. Under the terms, Sanofi will acquire rights to develop and commercialize investigational plozasiran in Greater China
Firm News July 8, 2025
Gibson Dunn Represented Constellation Wealth Capital in Minority Investment in Merit Financial Advisors
Gibson Dunn advised Constellation Wealth Capital, an alternative asset management platform focused on supporting the long-term growth of independent wealth management firms, on its strategic minority investment in Merit Financial Advisors
Firm News July 7, 2025
Gibson Dunn Represented Bank of America and Other Initial Purchasers on AMC Network’s $400 Million Senior Secured Notes
Gibson Dunn advised Bank of America and the other initial purchasers on AMC Network's $400 million 10.500% Senior Secured Notes due 2032.